T-CYPHER BIO
T-Cypher Bio is an early-stage biotechnology company. T-Cypher Bio we believe that TCR-based therapeutics have the potential to transform the treatment of solid tumors, as well as autoimmune, inflammatory, and infectious diseases. Yet challenges in the identification of therapeutically relevant targets and TCRs have limited the application of such therapies. T-Cypher’s integrated platform, D-Cypher, overcomes these challenges.
T-CYPHER BIO
Social Links:
Industry:
Biotechnology
Founded:
2020-08-27
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.tcypherbio.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Amazon Bamboo HR
Similar Organizations
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
ExoLytics
ExoLytics is an early-stage biotechnology company.
Fortis Biosciences
Fortis Biosciences is an early-stage biotech startup company.
Homebiotic
Homebiotic is an environmental probiotic technology developer company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Onward Therapeutics
Onward Therapeutics is a development stage oncology company.
ProNeurogen
ProNeurogen is an early-stage biotech company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Oxford Science Enterprises
Oxford Science Enterprises investment in Seed Round - T-Cypher Bio
Official Site Inspections
http://www.tcypherbio.com
- Host name: 94-237-62-61.uk-lon1.upcloud.host
- IP address: 94.237.62.61
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "T-Cypher Bio"
T-Cypher Bio - Crunchbase Company Profile & Funding
T-Cypher Bio is an early-stage biotechnology company. T-Cypher Bio we believe that TCR-based therapeutics have the potential to transform the treatment of …See details»
T-Cypher Bio Company Profile 2024: Valuation, …
Dec 21, 2020 T-Cypher Bio General Information Description. Developer of T-cell receptor-based therapeutics intended to provide a novel approach to cancer aid. The company's therapies utilize state-of-the-art techniques to identify a broad …See details»
T-Cypher Bio - Company Profile & Staff Directory - ContactOut
T-Cypher Bio is an early-stage, innovative biotechnology company based in Oxford, UK. We believe that TCR-based therapeutics have the potential to transform the treatment of solid …See details»
Imprint - T-CypherBio
Mar 17, 2024 This imprint was last updated on March 17, 2024. The owner of this website is: T-Cypher Bio Limited Limited The Sherard Building Edmund Halley RoadSee details»
T-Cypher Bio Overview | SignalHire Company Profile
Organization Website: tcypherbio.com : Social Links: T-Cypher Bio industries Biotech: Headquarters Location: Oxford, GB Oxford, GB : T-Cypher Bio Employees Size 10-50 …See details»
T-Cypher Bio Information - RocketReach
At T-Cypher Bio we generate novel TCR-based therapeutics that have the potential to transform the treatment of immune-mediated disease. Our proprietary platforms provide unique insight …See details»
T-Cypher Bio Company Overview, Contact Details & Competitors
Innovative TCR-based Therapeutics T-Cypher Bio specializes in developing novel TCR-based therapeutics that can revolutionize the treatment of immune-mediated diseases, presenting a …See details»
T-Cypher Bio Announces Formation of Scientific Advisory Board
Email: [email protected] Amber Fennell / Alexandra Harrison / Aaron Kelly Phone: +44 (0)20 3709 5701 Email: [email protected] About T-Cypher Bio T-Cypher Bio, a …See details»
T-Cypher Bio Ltd.: Drug pipelines, Patents, Clinical trials - Synapse
Explore T-Cypher Bio Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
T-Cypher Bio - Medicxi
At T-Cypher Bio we generate TCR-based therapeutics that have the potential to transform the treatment of solid tumours, autoimmune, inflammatory, and infectious diseases.See details»
T-Cypher Bio - VentureRadar
Similar Companies: immunoSCAPE USA Privately Held ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR …See details»
T-Cypher Bio – Funding, Valuation, Investors, News | Parsers VC
Jul 29, 2021 T-Cypher Bio is an early-stage, innovative biotechnology company based in Oxford, UK. We believe that TCR-based therapeutics have the potential to transform the treatment of …See details»
T-Cypher Bio - VentureRadar
Website: https://tcypherbio.com. Develops TCR-based therapeutics for solid tumors, autoimmune, inflammatory, and infectious diseases using a proprietary automated microfluidic discovery …See details»
T-Cypher Bio | LinkedIn
T-Cypher Bio | 1,774 followers on LinkedIn. Unlocking an expansive target space to build a pipeline of novel, TCR-based therapeutics. | T-Cypher Bio is an early-stage, innovative …See details»
T-Cypher Bio announces the appointment of Thomas Lars …
Email: [email protected] Amber Fennell / Alexandra Harrison / Aaron Kelly Phone: +44 (0)20 3709 5701 Email: [email protected] About T-Cypher Bio T-Cypher Bio, a …See details»
T-Cypher Bio separates from Orbit Discovery to build a
Feb 25, 2021 T-Cypher Bio: Consilium Strategic Communications : Uciane Scarlett, Interim Executive Chair Email: [email protected]: Amber Fennell / Alexandra Harrison / Aaron …See details»
Careers - T-CypherBio
Please click below to apply to one of our open positions or, if you have in-depth experience in T cell biology, immunology, bioinformatics, or AI and/or TCR discovery and development, send …See details»
Privacy Statement (UK) - T-CypherBio
In this privacy statement, we explain what we do with the data we obtain about you via https://tcypherbio.com. We recommend you carefully read this statement. In our processing we …See details»
Website Style Guide - T-CypherBio
Below is an overview of responsive typography sizes and weights for this site. These are computed from a base size and a mathematical scale.See details»